By Abinger Investments Limited Abinger Investments has released a new report highlighting the recent acquisition of genetic testing company 23andMe Holding Co. by biotechnology leader Regeneron Pharmaceuticals, Inc.
|
By Abinger Investments Limited A recent study from Abinger Investments highlights Warner Bros. Discovery (WBD) share growth due to investor confidence in streaming and media.
|
By Abinger Investments Limited In its latest technology sector report, Abinger Investments highlights Meta Platforms Inc.'s intention to considerably increase its capital expenditures in 2025, focusing on AI infrastructure.
|
By Abinger Investments Limited Abinger Investments' new economic prediction assesses the inflationary risks of restored trade tensions under former President Donald Trump's proposed tariff measures, assuming he runs again.
|
By Abinger Investments Limited The latest quarterly market commentary from Abinger Investments Limited emphasizes the importance of high-growth assets and strategic investments in high-performing sectors as drivers of excellent portfolio performance.
|
